Bill & Melinda Gates Foundation launch initiative for future pandemics
The initiative will catalyse discovery and early development of antiviral medicines for future pandemics
Read More
Author: John Pinching
COVID-19 infections seeing spike across UK
In the coming months, an additional vaccine booster will be offered to those over 75, care home residents and to those over 12 who are most vulnerable
Read More
State-of-the-art R&D facilities to be developed in Oxford city centre
Site will include creating space for student accommodation, offices, retail outlets and restaurants
Read More
Abivax reports promising rheumatoid arthritis results
Treatment demonstrated a good safety profile in the overall patient population during the 12-week induction phase
Read More
Waiting times for cancer referrals highest on record
93% of people suspected by GPs to have cancer should be seen by a specialist within two weeks but this has fallen to just 75%
Read More- DNA Script signs SYNTAX distribution agreements with Gencell, BMS and Biostream
- Ondine’s Steriwave phase 3 trial reaches 93% enrolment milestone
- Arvinas reports strong phase 1 results for ARV-102 in Parkinson’s disease
- Alzecure shares new preclinical data on NeuroRestore ACD856 at AD/PD conference
- Samsung Bioepis signs partnership with Sandoz for next‑generation biosimilars
